TrialAdvances in therapy2024

A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants.

Hong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.